Discover 1,556 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,556
Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
for
Major Depressive Disorder
Location: 33 recruiting locations
Sponsor: Neumora Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06058013
Phase3, Recruiting
Active & ResponsiveNew
Improving Executive Control in Cognitively Healthy Older Adults: the MUltitasking STrategy (MUST) Study
for
Healthy Aging, Alzheimer's Disease (AD)
Location: 1 recruiting location
Sponsor: Rutgers, The State University of New Jersey
Sex: All
Age: 60 - 70+
Code: NCT06995638
Recruiting
Active & ResponsiveNew
The Role of Macrophage Activation in Lung Injury Following Ozone Exposure
for
Air Pollution
Location: 1 recruiting location
Sponsor: Rutgers, The State University of New Jersey
Sex: All
Age: 18 - 40
Code: NCT05794087
Recruiting
Active & ResponsiveNew
IVIG vs SCIG in CIDP
for
CIDP, Immunoglobulin Deficiency,
Location: 1 recruiting location
Sponsor: Rutgers, The State University of New Jersey
Sex: All
Age: 18 - 65
Code: NCT05584631
Phase1, Recruiting
Active & Responsive
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
for
Psoriasis, Overweight or Obesity
Location: 42 recruiting locations
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06857942
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
for
Colorectal Neoplasms, Breast Neoplasms, Head and Neck Neoplasms,
Location: 9 recruiting locations
Sponsor: Rutgers, The State University of New Jersey
Sex: All
Age: 18+
Code: NCT07158164
Recruiting
Active & Responsive
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: 40 recruiting locations
Sponsor: Bicara Therapeutics
Sex: All
Age: 18+
Code: NCT06788990
Phase2, Phase3, Recruiting
Active & Responsive
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
for
Intracranial Arteriosclerosis, Stroke
Location: 77 recruiting locations
Sponsor: University of Florida
Sex: All
Age: 30+
Code: NCT05047172
Phase3, Recruiting
Active & Responsive
Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis
Location: 50 recruiting locations
Sponsor: Gilead Sciences
Sex: All
Age: 18 - 70+
Code: NCT06290934
Phase2, Recruiting
Active & Responsive
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
for
Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome